CytomX Therapeutics Inc (CTMX:NASDAQ)

$5.48 -0.31 (-5.35%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 91

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed CytomX Therapeutics Inc (CTMX:NASDAQ) News Sources

Why CytomX Therapeutics, Inc.’s (CTMX) Stock Is Up 7.44%

American Association of Individual Investors

external link

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

The Economic Times

external link
CTMX stock
CTMX stock price
CTMX stock price today
CTMX stock prediction
CTMX earnings date
CTMX news
CTMX price
CTMX share
CTMX share price
CTMX shares
CTMX ceo
CTMX premarket
$CTMX
CTMX ticker
CTMX after hours
CTMX stock
CTMX stock price
CTMX stock price today
CTMX stock prediction
CTMX earnings date
CTMX news
CTMX price
CTMX share
CTMX share price
CTMX shares
CTMX ceo
CTMX premarket
$CTMX
CTMX ticker
CTMX after hours

CytomX Therapeutics Inc (CTMX:NASDAQ) FAQs

toggle

What is the current price of CytomX Therapeutics Inc (CTMX:NASDAQ)?

The current price of CytomX Therapeutics Inc (CTMX:NASDAQ) is $5.48.


toggle

CytomX Therapeutics Inc (CTMX:NASDAQ) absolute price change since previous trading day?

The absolute price change of CytomX Therapeutics Inc (CTMX:NASDAQ) since the previous trading day is $-0.31.


toggle

CytomX Therapeutics Inc (CTMX:NASDAQ) percentage price change since previous trading day?

The percentage price change of CytomX Therapeutics Inc (CTMX:NASDAQ) since the previous trading day is -5.35%.


toggle

What is This Week's average sentiment score for CytomX Therapeutics Inc (CTMX:NASDAQ)?

This Week's average sentiment score for CytomX Therapeutics Inc (CTMX:NASDAQ) is 91 out of 100.


toggle

What is This Week's average sentiment for CytomX Therapeutics Inc (CTMX:NASDAQ)?

This Week's sentiment for CytomX Therapeutics Inc (CTMX:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.